リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Amniotic Fluid L-Type Fatty Acid-Binding Protein in Predicting Fetal Condition.」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Amniotic Fluid L-Type Fatty Acid-Binding Protein in Predicting Fetal Condition.

KATSURA Daisuke 0000-0002-5357-5700 TSUJI Shunichiro 30601546 0000-0003-3945-6817 HAYASHI Kaori 70569251 TOKORO Shinsuke 20613475 ZEN Rika HOSHIYAMA Takako KIMURA Fuminori 90322148 0000-0002-9840-4227 KITA Nobuyuki 20273419 MURAKAMI Takashi 20240666 0000-0002-0250-0856 滋賀医科大学

2021.08.21

概要

Ultrasonography and fetal heart rate monitoring are subjective assessments of fetal condition, which warrants the need for objective markers to predict fetal condition. Urinary L-type fatty acid-binding protein (L-FABP) levels correlate with hypoperfusion. Elevated amniotic fluid L-FABP levels may represent fetal tissue hypoperfusion since the amniotic fluid contains fetal urine. In this study, we aimed to analyze the effectiveness of amniotic fluid L-FABP as a predictor of fetal condition. We classified singleton pregnancies into groups based on fetal growth restriction (FGR) with and without fetal blood flow abnormalities (FGR and healthy-FGR groups, respectively) and the non-FGR group (control group). We collected amniotic fluid at the time of vaginal delivery, cesarean section and amniocentesis, and compared the patient characteristics, clinical outcomes and amniotic fluid levels of L-FABP between the groups. We analyzed 153 singleton pregnancies and 186 amniotic fluid samples (FGR group, 6 (3.9%) pregnancies and 23 (12.4%) samples; healthy-FGR group, 15 (9.8%) pregnancies and 20 (10.7%) samples; control group, 132 (86.3%) pregnancies and 143 (76.9%) samples). The amniotic fluid L-FABP level was significantly higher in the FGR group compared to that in the healthy-FGR and control groups. Multivariate analysis revealed that the amniotic fluid L-FABP level was not affected by fetal body weight. Additionally, the amniotic fluid L-FABP levels increased significantly in cases with fetal blood flow abnormalities or early gestational age. Therefore, amniotic fluid L-FABP level may be an objective and accurate predictive marker of fetal condition.

この論文で使われている画像

関連論文

参考文献

Asada, T., Isshiki, R., Hayase, N., Sumida, M., Inokuchi, R., Noiri,

E., Nangaku, M., Yahagi, N. & Doi, K. (2016) Impact of clinical context on acute kidney injury biomarker performances:

differences between neutrophil gelatinase-associated lipocalin

and L-type fatty acid-binding protein. Sci. Rep., 6, 33077.

Baschat, A.A. (2010) Ductus venosus Doppler for fetal surveillance in high-risk pregnancies. Clin. Obstet. Gynecol., 53,

858-868.

Baschat, A.A. (2011) Neurodevelopment following fetal growth

restriction and its relationship with antepartum parameters of

placental dysfunction. Ultrasound Obstet. Gynecol., 37,

501-514.

Baschat, A.A., Viscardi, R.M., Hussey-Gardner, B., Hashmi, N. &

Harman, C. (2009) Infant neurodevelopment following fetal

growth restriction: relationship with antepartum surveillance

parameters. Ultrasound Obstet. Gynecol., 33, 44-50.

Bennaars-Eiden, A., Higgins, L., Hertzel, A.V., Kapphahn, R.J.,

Ferrington, D.A. & Bernlohr, D.A. (2002) Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant

biology. J. Biol. Chem., 277, 50693-50702.

Derikx, J.P., Poeze, M., van Bijnen, A.A., Buurman, W.A. &

Heineman, E. (2007) Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock, 28,

544-548.

Figueras, F. & Gratacos, E. (2014) Update on the diagnosis and

classification of fetal growth restriction and proposal of a

stage-based management protocol. Fetal Diagn. Ther., 36,

86-98.

Gluckman, P.D., Hanson, M.A. & Beedle, A.S. (2007) Early life

events and their consequences for later disease: a life history

and evolutionary perspective. Am. J. Hum. Biol., 19, 1-19.

Gluckman, P.D., Hanson, M.A., Spencer, H.G. & Bateson, P.

(2005) Environmental influences during development and

their later consequences for health and disease: implications

for the interpretation of empirical studies. Proc. Biol. Sci.,

272, 671-677.

Iwagaki, S., Takahashi, Y., Chiaki, R., Asai, K., Matsui, M., Mori,

T. & Kawabata, I. (2019) Hypercoiled cord can cause a

reversible abnormal Doppler in ductus venosus in cases of

fetal growth restriction. J. Obstet. Gynaecol. Res., 44, 19221928.

L-type Fatty Acid-Binding Protein Predicts Fetal Condition

Kalogiannidis, I., Prapa, S., Dagklis, T., Karkanaki, A., Petousis,

S., Prapas, Y. & Prapas, N. (2011) Amniocentesis-related

adverse outcomes according to placental location and risk

factors for fetal loss after midtrimester amniocentesis. Clin.

Exp. Obstet. Gynecol., 38, 239-242.

Kanda, Y. (2013) Investigation of the freely available easy-to-use

software ‘EZR’ for medical statistics. Bone Marrow Transplant., 48, 452-458.

Katsura, D., Takahashi, Y., Iwagaki, S., Chiaki, R., Asai, K., Koike,

M., Nagai, R., Yasumi, S. & Furuhashi, M. (2019) Amnioinfusion for variable decelerations caused by umbilical cord

compression without oligohydramnios but with the sandwich

sign as an early marker of deterioration. J. Obstet. Gynaecol.,

39, 49-53.

Khare, M., Paul, S. & Konje, J.C. (2006) Variation in Doppler

indices along the length of the cord from the intraabdominal to

the placental insertion. Acta Obstet. Gynecol. Scand., 85,

922-928.

Lees, C.C., Marlow, N., van Wassenaer-Leemhuis, A., Arabin, B.,

Bilardo, C.M., Brezinka, C., Calvert, S., Derks, J.B., Diemert,

A., Duvekot, J.J., Ferrazzi, E., Frusca, T., Ganzevoort, W.,

Hecher, K., Martinelli, P., et al. (2015) 2 year neurodevelopmental and intermediate perinatal outcomes in infants with

very preterm fetal growth restriction (TRUFFLE): a

randomised trial. Lancet, 385, 2162-2172.

Li, H., Gudmundsson, S. & Olofsson, P. (2006) Acute centralization of blood flow in compromised human fetuses evoked by

uterine contractions. Early Hum. Dev., 82, 747-752.

Manning, F.A. (1999) Fetal biophysical profile. Obstet. Gynecol.

Clin. North Am., 26, 557-577.

273

Shinozuka, N. (2002) Fetal biometry and fetal weight estimation:

JSUM standardization. Ultrasound Rev. Obstet. Gynecol., 2,

156-161.

Takahashi, Y., Iwagaki, S., Chiaki, R., Iwasa, T., Takenaka, M.,

Kawabata, I. & Itoh, M. (2014) Amnioinfusion before 26

weeks’ gestation for severe fetal growth restriction with oligohydramnios: preliminary pilot study. J. Obstet. Gynaecol.

Res., 40, 677-685.

The GRIT Study Group (Growth Restriction Intervention Trial)

(1996) When do obstetricians recommend delivery for a highrisk preterm growth-retarded fetus? Eur. J. Obstet. Gynecol.

Reprod. Biol., 67, 121-126.

Tonomura, Y., Uehara, T., Yamamoto, E., Torii, M. & Matsubara,

M. (2011) Decrease in urinary creatinine in acute kidney

injury influences diagnostic value of urinary biomarker-tocreatinine ratio in rats. Toxicology, 290, 241-248.

Vossbeck, S., de Camargo, O.K., Grab, D., Bode, H. & Pohlandt, F.

(2001) Neonatal and neurodevelopmental outcome in infants

born before 30 weeks of gestation with absent or reversed enddiastolic flow velocities in the umbilical artery. Eur. J.

Pediatr., 160, 128-134.

Wang, G., Gong, Y., Anderson, J., Sun, D., Minuk, G., Roberts,

M.S. & Burczynski, F.J. (2005) Antioxidative function of

L-FABP in L-FABP stably transfected chang liver cells.

Hepatology, 42, 871-879.

Yamamoto, T., Noiri, E., Ono, Y., Doi, K., Negishi, K., Kamijo, A.,

Kimura, K., Fujita, T., Kinukawa, T., Taniguchi, H., Nakamura, K., Goto, M., Shinozaki, N., Ohshima, S. & Sugaya, T.

(2007) Renal L-type fatty acid--binding protein in acute ischemic injury. J. Am. Soc. Nephrol., 18, 2894-2902.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る